Introducing the Tekton Alzheimer’s Team

Tekton is introducing its Alzheimer's Team, bringing together practicing physician-investigators, experienced neuroscience raters, and clinical and operational leaders to advance research across six lead sites.

The team's focus includes Alzheimer's disease, mild cognitive impairment (MCI), and agitation associated with Alzheimer's disease. Its clinical expertise spans memory loss, dementia, geriatric psychiatry, and related conditions.

For Sponsors and CROs, the team provides coordinated input on study opportunities, protocol fit, participant access, cognitive and behavioral assessment requirements, and study delivery. That work includes reviewing rater needs, diagnostic capabilities, and the practical demands of study visits for participants and their study partners.

Meet the team

The Tekton Alzheimer's Team includes:

• Jeffrey Shenfeld, MD
• Ernest Graypel, MD, MHA
• Ravi Singareddy, MD
• Amor Mehta, MD
• Amit Vijapura, MD
• Patricia Brown, PhD, APRN
• Jeffrey Zucker
• Brandon Lenfest

Together, the team combines practicing physician expertise with assessment experience and operational support for participating sites.

Six lead sites, with additional diagnostic and screening support

The team's six lead locations are Suwanee, GA; St. Louis, MO; Englewood and Marlboro, NJ; Suffern, NY; and Coppell, TX.

Additional Tekton sites can support higher-volume Alzheimer's-related diagnostic and screening studies. Site recommendations depend on protocol requirements, relevant participant populations, investigator expertise, rater qualifications, diagnostic access, and operational readiness.

Sponsors and CROs can connect with the team to discuss a protocol, evaluate potential sites, and meet investigators whose expertise aligns with their study.